Expiring drug patents to plunge
As sources to copy dry up, makers of generics look to redefine themselves
Posted: December 23, 2012 at 2:36 a.m.
A lab technician works with sterile products during drug manufacturing at a plant owned by Teva Pharmaceuticals Industries Ltd.’s factory in Godollo, Hungary, in October. Teva is the world’s largest maker of generic drugs.
They call it the patent cliff. Brand-name drugmakers have feared it for years. And now generic-drug makers fear it, too.
This story is only available from our archives.
Business, Pages 67 on 12/23/2012
(Advertisement)
« Previous Story
University and Markham will become a hot inte...
You knew it would come to this. McDonald’s has lost count of how many hamburgers it has sold. Read »
Next Story »
2nd crop causes baiting law flap for rice far...
Some Arkansas rice farmers who took advantage of 2012’s warm spring to get a jump on planting saw a rare opportunity this fall for a second harvest, called a “ratoon” crop. Read »
Comments
To report abuse or misuse of this area please hit the "Suggest Removal" link in the comment to alert our online managers. Please read our comment policy.
Use the comment form below to begin a discussion about this content.
Registration is required to make comments. Click here to LOGIN.
You can register for FREE to post comments and receive alerts.